Potential true theranostic agent for cancer produced
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Showing 141 - 160 of 1603 results
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.
Modified component of green tea promises potential neuroblastoma treatment.
Doping with transition metals produced stability in bismuth oxide.
Scientists and researchers within ANSTO's Australian Centre for Neutron Scattering area have been published in a wide range of publications and have presented at many conferences.
A team of Melbourne researchers and international partners from Italian Instituto Nazionale de Fisica Nucleare (INFN) and CERN, who are developing radiation-hardened semiconductor chips, used the unique state-of-art high energy ion microprobe on the SIRIUS ion accelerator at ANSTO’s Centre for Accelerator Science to test a prototype radiation-resistant computer chip
There has been an increasing pressure on construction industrial sector to utilise innovative materials that not only meet the requirements of ambitious architectural designs, but also reduce CO2 emissions.
Australia part of global renaissance in fusion power research symbolised by ITER experiment
Study revealed that the chemical forms of sulfur change when land is converted from undisturbed soils to cropping soils and forms of sulfur which bind strongly to the soil mineral particles remains far more stable.